MedPath

Management of Prostate Cancer in Central China

Completed
Conditions
Prostate Cancer
Registration Number
NCT01614548
Lead Sponsor
Zhengzhou University
Brief Summary

Some recent reports indicate that incidence of prostate cancer is increasing rapidly in China. However, no large-scale survey of prostate cancer has been done in central China, few data are available regarding its management. The investigators aimed to analyze the management of prostate cancer and compare the outcome of patients with such a survey.

The investigators collected data of patients diagnosed with prostate cancer from the 2003 and 2008 in central China. Data were disaggregated by rural and urban hukou. The survival rate of patients was analyzed using Kaplan-Meier method. Prognostic factors were analyzed using the log-rank test and Cox proportional hazards model.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
789
Inclusion Criteria
  • patients with newly diagnosed prostate cancer were included in the study.
Exclusion Criteria
  • Those with a history of prostate cancer who were treated for another disease were excluded from study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
overall survival3 years

overall survival that was defined as the interval from the date of diagnosis to the Medicare date of death

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

the first affiliated hospital of Zhengzhou University

🇨🇳

Zhengzhou, Henan, China

© Copyright 2025. All Rights Reserved by MedPath